In a study published in Nature Communications, researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), together with international collaborators, examined whether methylene blue could mitigate brain injury during severe malaria, and whether a practical set of blood biomarkers could help clinicians identify cerebral malaria early and track how patients respond to treatment.